Veterinary Orthopedic Medicine Market Report 2026

The veterinary orthopedic medicine market size has grown strongly in recent years. It will grow from $4.03 billion in 2025 to $4.4 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to high incidence of osteoarthritis and joint disorders, growth in companion animal population, limited availability of advanced orthopedic treatments in early years, increasing equine and canine sports activities, expansion of veterinary hospitals and clinics.

The veterinary orthopedic medicine market size is expected to see strong growth in the next few years. It will grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to advancements in prp and stem cell therapies, increasing use of viscosupplements and nsaids, adoption of advanced surgical techniques, growing investment in veterinary orthopedic research, rising awareness of animal mobility and quality of life. Major trends in the forecast period include rising prevalence of musculoskeletal disorders in animals, increasing adoption of minimally invasive orthopedic surgeries, growth in stem cell and biologics-based treatments, expansion of veterinary rehabilitation and physiotherapy services, emphasis on pain management and post-surgery recovery.

The rising incidence of pet orthopedic diseases is anticipated to drive the growth of the veterinary orthopedic medicine market in the coming years. Pet orthopedic diseases are conditions that affect the musculoskeletal system of companion animals, especially dogs and cats. The growing occurrence of these conditions is linked to factors such as breed-related predispositions, increasing obesity levels, and environmental influences including insufficient physical activity and poor nutrition. Veterinary orthopedic medicine is essential for the diagnosis, treatment, and management of orthopedic disorders in pets, helping to reduce pain, restore mobility, and enhance overall quality of life. For example, in July 2024, according to a report published by the Morris Animal Foundation, a U.S.-based non-profit organization, more than 14 million adult dogs in the United States were reported to suffer from osteoarthritis. Additionally, data shows that nearly 90% of cats over the age of 12 display radiographic signs of osteoarthritis, emphasizing the widespread nature of this condition among aging pets and highlighting the increasing need for improved awareness and advanced treatment options. Therefore, the rising incidence of pet orthopedic diseases is contributing to the growth of the veterinary orthopedic medicine market.

Major companies operating in the veterinary orthopedic medicine market are increasingly investing in advanced technologies such as 3D printing laboratories for customized implants, regenerative medicine approaches including stem cell and platelet-rich plasma (PRP) therapies, and sophisticated imaging techniques like MRI and CT scans designed specifically for animal patients. A 3D printing lab for pet orthopedic surgeries is a specialized facility that applies 3D printing technology to produce custom implants, prosthetics, and surgical tools tailored for veterinary orthopedic procedures. For instance, in October 2024, VCA Animal Hospitals, a U.S.-based provider of veterinary care services, launched a 3D printing lab at its VCA Northwest Veterinary Specialists facility in Clackamas, Oregon. This lab leverages advanced 3D printing technology to improve orthopedic surgeries for pets by developing custom implants and surgical guides based on each animal’s unique anatomy. Osteoarthritis, which affects approximately 20% of dogs over one year of age and nearly 80% of dogs older than eight years, often requires surgical intervention. Through this personalized approach, VCA aims to support faster recovery and better surgical outcomes, enabling more effective treatment of complex orthopedic conditions compared to conventional methods.

In March 2025, Creative Science, a U.S.-based veterinary medical technology company, acquired Infiniti Medical LLC and its subsidiary Orthomed UK Ltd. for an undisclosed sum. Through this acquisition, Creative Science sought to broaden its veterinary innovation portfolio by strengthening its product range and educational programs in areas such as interventional radiology, cardiology, soft tissue surgery, and orthopedic veterinary care. Infiniti Medical LLC is a U.S.-based veterinary medical technology company focused on the development of advanced veterinary technologies and medical devices.

Major companies operating in the veterinary orthopedic medicine market are Zoetis Inc., Elanco Animal Health, Merck Animal Health, Virbac SA, Ceva Santé Animale, Vetoquinol S.A., Bimeda U.S., American Regent, Hyalogic LLC, BioMedtrix LLC, IMEX Veterinary Inc., Orthomed (UK) Ltd, Veterinary Orthopedic Implants, Integra LifeSciences, Avante Animal Health, DePuy Synthes Vet, KYON AG, Securos Surgical, Arthrex Vet Systems, INNOPLANT Medizintechnik GmbH, VetWelding AG, Scil Animal Care, Intrauma S.p.A., Aysam Veterinary Orthopedics.

North America was the largest region in the veterinary orthopedic medicine market in 2025. The regions covered in the veterinary orthopedic medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary orthopedic medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the veterinary orthopedic medicine market by increasing the costs of imported biologics, viscosupplements, and pharmaceutical products, affecting production and pricing. Regions such as north america and asia-pacific are most affected due to dependency on imported therapies and surgical equipment. Segments like stem cell therapy, prp, and hyaluronic acid injections have faced cost pressures, while tariffs have encouraged domestic manufacturing and innovation in cost-effective treatment solutions. Overall, tariffs have prompted companies to diversify sourcing and strengthen local supply chains.

The veterinary orthopedic medicine market research report is one of a series of new reports that provides veterinary orthopedic medicine market statistics, including veterinary orthopedic medicine industry global market size, regional shares, competitors with a veterinary orthopedic medicine market share, detailed veterinary orthopedic medicine market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary orthopedic medicine industry. This veterinary orthopedic medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary orthopedic medicine constitutes a distinct discipline within veterinary practice, concentrating on the identification, management, and prevention of musculoskeletal disorders and injuries in animals. This field encompasses a spectrum of conditions, including fractures, arthritis, congenital abnormalities, and soft tissue injuries, and entails diverse treatment modalities such as surgical procedures, physical therapy, and rehabilitation, all aimed at reinstating mobility and function in animals.

The primary products of veterinary orthopedic medicine include biologics, viscosupplements, and pharmaceuticals. Biologics are derived from living cells or organisms and are utilized to treat diseases or injuries in various animal species such as dogs, cats, horses, cattle, pigs, and others. These products find multiple applications, including the management of osteoarthritis, degenerative joint disease, joint inflammation or pain, and more, and are employed by veterinary hospitals, clinics, and other end-users.

The veterinary orthopedic medicine market includes revenues earned by entities by providing services such as diagnosing, treating, and preventing musculoskeletal disorders and injuries in animals. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary orthopedic medicine market also includes sales of external fixation devices, intramedullary devices, and joint implants. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.